All News

CURE spoke with an expert to discuss financial toxicity and the important of seeking support after receiving a cancer diagnosis.

What are the odds that my friend, Michael, would be afflicted with the same rare disease that I had?

From celebrity news to a new partnership aimed to help patients and their caregivers, here’s what is making headlines in the cancer space this week.

To tell or not to tell? That is a question I ask myself at the start of every school year. Do I tell my children's teachers I have cancer?

When I have my “what if” moments, I remember this: Try to take things one day at a time.

Once you try this week’s #CURESummerSnacktime recipe for Peanut Butter Banana Ice Cream, we bet you’ll be adding this cool, creamy concoction into your weekly rotation.

In a new study, Zejula (niraparib) has been shown to prolong life for patients with ovarian cancer who have already undergone four or more rounds of chemotherapy.

A nearly 10-year stomach cancer survivor works with Debbie’s Dream Foundation to raise disease awareness and raise money for a cure.

My hospital made complete visit notes after my cancer diagnosis available online and what I found in them is a gift of gratitude and shared awe.

After almost a decade with no new treatments, Inrebic offers patients with myelofibrosis new hope for the future.

When a person moves out of their active treatment phase and begins the shift to life after cancer, many unanswered questions lie ahead. Some institutions offer courses to help with just that.

When non-small cell lung cancer spreads to just a few sites, therapy can be given with curative intent – and immunotherapy can help delay relapse.

Some of the greatest doctors in the world were responsible for my survival and recovery from acute myeloid leukemia…but the Three Stooges, W.C Fields, Abbott and Costello, Laurel and Hardy and The Marx Brothers played a major role as well.

Following its announcement of covering chimeric antigen receptor-T cell therapy nationwide, the Centers for Medicare and Medicaid Services has now made this highly-priced, but life-saving, treatment available to many who would not otherwise have access to it at their cancer centers.

There I was with my freshly darkened skin in the mirror (after a beautiful day out in the sun). What was I thinking? Oh yeah, I wasn’t thinking.

The Food and Drug Administration approved Inrebic as the first new treatment in nearly a decade for patients with myelofibrosis.

From an FDA warning to real-life superheroes, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Rozlytrek (entrectinib) for adult and adolescent patients 12 years of age and older whose cancers have the NTRK gene fusion and for adults with non-small cell lung cancer whose tumors are ROS1-positive and have spread to other parts of the body.

We asked our social media audience: How do you overcome the fear that comes with cancer? Here are some of their inspiring, uplifting and surprising responses.

Patients with gastrointestinal cancers should be aware of specific side effects that might arise — and ways to prevent or ease them.

Progress in cancer comes slowly, in bits and pieces and not in sudden bursts of success. And even when “breakthroughs” happen, it usually takes a long time to confirm that the early results actually make a difference.

A male breast cancer survivor learns the true meaning of the word "advocate."

There are resources available to help you cope with financial stress of cancer, whether it's you or a loved one facing the disease.

Here’s a sneak peak at what is inside Heal’s Summer 2019 issue.

Those with a first-degree relative diagnosed with certain blood cancers may be at an increased risk for developing the disease themselves.

This week’s refreshing Summer Snacktime recipe makes our editors hungry just by looking at it. If you’re a fan of basil, strawberries or ricotta, we think it might have the same effect on you!

Given the hardships cancer can have on an individual and their loved ones, support groups can be a useful tool in navigating the new normal.

A recent study found that only a quarter of women with breast cancer and a third of women with ovarian cancer had undergone genetic testing. Memorial Sloan Kettering experts say these numbers are surprisingly low.